Gary Howes

Gary Howes is a partner in Fasken Martineau DuMoulin LLP and Managing Partner of Fasken Martineau LLP (London). He is a member of Technology and Intellectual Property and Life Sciences practice groups.  

Gary works almost exclusively in the pharmaceutical and biotech sectors advising on IP, commercial and regulatory matters, patent licensing and product acquisitions and disposals. His clients are private and public companies, and include Antisoma, SkyePharma and UCB. Clients benefit from Gary's acute industry specialisation, which enables him to provide legal advice within the context of the relevant commercial and regulatory background. Advice "in a vacuum" is never provided.

Gary is named by European Counsel Life Science's Industry Report in its 'Super League for Intellectual Property'. Global Counsel has also 'highly recommended' him for his work in patent expertise, commercial IP and protection issues. He is regularly recommended in the Legal 500 and in Chambers UK, where he is referred to as a "marvel in commercial agreements". That publication also said "clients endorsed his incisive intellectual ability to reduce problems" and his "ability to communicate well with laymen in non-legal terms."

In 2007 Gary was short listed for "Deal Lawyer of the Year" award at the British Legal Awards which are sponsored by Legal Week.

Selected Experience

• Theratechnologies enters into distribution & licensing agreement for Tesamorelin in Europe
• Summit Awarded £2.2 Million from The Wellcome Trust

News

• Gary Howes and Allistair Booth are featured in a list of the 20 most talented IP transactional lawyers in the UK, as published on the blog IP Draughts
• Fasken Martineau Sponsors Québec Annual Lecture, "An Evening in Space with Julie Payette"

Publications

• Fasken Martineau's Life Sciences Newsletter

Presentations

• Biomedex 2008 - Globalization and growth perspectives

Membership/Affiliations

• Law Society
• Licensing Executives Society
• BioIndustry Association (BIA)
• Association of British Pharmaceutical Industry (ABPI)

Honours and Awards

• Recognised by Chambers UK as a 'Leader in their field' within 'Life Sciences: Transactional UK-wide'; Gary is highlighted as a 'transactional specialist with a wealth of experience in life sciences'. 'Clients find him "a dream to work with - he doesn't have his own agenda or feel the need to over-exert his position"' (2012 edition)
• Recommended by Intellectual Asset Management (IAM) magazine as one of the top 250 patent and technology licensing lawyers worldwide. Clients cite him as "exceedingly knowledgeable" and praise him for concentrating "on the practical issues" and finding "effective solutions" (2011/2012 edition) 
• Recognised by Legal 500 for his expertise in the field of 'Pharmaceuticals and Biotechnology' (2011 edition)
• Recognised by Chambers UK as a 'Leader in their field' within 'Life Sciences: Transactional UK-wide'; Gary is praised for being "attentive to his clients", finding "practical solutions" and producing "high-quailty work" (2011 edition)
• Recognised by Who's Who Legal as a leader in the field of Life Sciences (2010 and 2011 editions)
• Recognised by Legal Experts as an authority in the field of Intellectual Property (2010 and 2011 editions)
• Recommended by Intellectual Asset Management (IAM) magazine as one of the top 250 patent and technology licensing lawyers worldwide. Gary is praised for "his specialisation in the [pharmaceutical] industry" which "marks him out as a go-to figure for clients" (2010/2011 edition)
• Recognised by Chambers UK as a 'Leader in their field' within 'Life Sciences: Commercial/Corporate' (2009 and 2010 editions)
• Recognised by Best Lawyers for his expertise within the field of 'Life Sciences: Patent' (2009 edition)
• Recommended by PLC Which Lawyer? for his expertise within the field of 'Life Sciences: Commercial & Partnering' (2009 edition)
• Recognised by Chambers UK for his ability to "handle anything thrown at him" and for his "impressively committed and bright demeanour" (2009 edition)
• Recognised by Legal 500 and cited as being"extremely experienced" within the field of 'Pharmaceuticals and biotechnology' (2009 edition)
• Recognised by Chambers UK and highlighted for his "effective, cerebral approach to any project he tackles" (2008 edition)
• Recognised by Legal 500 and praised for being "knowledgeable" within the field of 'Pharmaceuticals and biotechnology' (2008 edition)
• Recognised by Chambers UK and cited as a "marvel in commercial agreements" (2007 edition)
• Recognised by Legal 500 and praised for being "extremely knowledgable" with regards to licence agreements (2007 edition)
• Recommended by PLC Which Lawyer? for his expertise in the field of 'Life Sciences: Commercial & Partnering' and is "best noted for his patent knowledge, especially in the licensing area" (2007 edition)